Closed‐system drug‐transfer devices in addition to safe handling of hazardous drugs versus safe handling alone for reducing healthcare staff exposure to infusional hazardous drugs
Información
- DOI:
- https://doi.org/10.1002/14651858.CD012860Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 13 noviembre 2017see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Protocol
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Salud laboral
- Copyright:
-
- Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Conceiving the protocol: KG.
Designing the protocol: KG.
Co‐ordinating the protocol: KG.
Designing search strategies: KG.
Writing the protocol: KG.
Providing general advice on the protocol: LB, CT, EL, MK, and JFB.
Securing funding for the protocol: KG.
Sources of support
Internal sources
-
No sources of support supplied
External sources
-
UK Oncology Nursing Society Board, UK.
Grant to the sum of GBP 12,000 provided to Kurinchi Gurusamy and Lawrence Best.
Declarations of interest
Kurinchi Gurusamy and Lawrence Best: We received a grant for GBP 12,000 from the UK Oncology Nursing Society to conduct this Cochrane Review.
Cynthia Tanguay: I am a member of the Working Committee on the Safe Handling of Hazardous Drugs established by the Association paritaire pour la santé et la sécurité du travail du secteur affaires sociales (ASSTSAS).
Elaine Lennan: None known.
Mika Korva: None known.
Jean‐François Bussières: I am a member of the Working Committee on the Safe Handling of Hazardous Drugs established by the Association paritaire pour la santé et la sécurité du travail du secteur affaires sociales (ASSTSAS).
The outcomes were chosen by the funders of this review, the board of the UK Oncology Nursing Society who represent the target population of the interventions evaluated. However, the peer referees also considered these outcomes to be the most important.
Acknowledgements
We thank Jani Ruotsalainen, Managing Editor, and Jos Verbeek, Co‐ordinating Editor from Cochrane Work Review Group for their help in all stages of the current protocol. We also thank the editors Alex Burdorf and Nicole Skoetz and external peer referee Thomas Connor for their comments and Anne Lawson for copy editing the text.
Version history
| Published | Title | Stage | Authors | Version |
| 2018 Mar 27 | Closed‐system drug‐transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff | Review | Kurinchi Selvan Gurusamy, Lawrence MJ Best, Cynthia Tanguay, Elaine Lennan, Mika Korva, Jean‐François Bussières | |
| 2017 Nov 13 | Closed‐system drug‐transfer devices in addition to safe handling of hazardous drugs versus safe handling alone for reducing healthcare staff exposure to infusional hazardous drugs | Protocol | Kurinchi Selvan Gurusamy, Lawrence MJ Best, Cynthia Tanguay, Elaine Lennan, Mika Korva, Jean‐François Bussières | |
Notes
Parts of the 'Methods' section and Appendix 1 of this protocol are based on a standard template established by the Cochrane Work Review Group. This review is independent research funded by the UK Oncology Nursing Society. The views expressed in this publication are those of the authors and not necessarily those of the UK Oncology Nursing Society.
Keywords
MeSH
Medical Subject Headings (MeSH) Keywords
- *Hazardous Substances [analysis, urine];
- *Nursing Staff, Hospital;
- *Pharmacists;
- *Pharmacy Technicians;
- Antineoplastic Agents [analysis, urine];
- Chemical Safety [*instrumentation, *methods];
- Cyclophosphamide [analysis, urine];
- Deoxycytidine [analogs & derivatives, analysis, urine];
- Endocrine Disruptors [analysis, urine];
- Fluorouracil [analysis, urine];
- Ifosfamide [analysis, urine];
- Observational Studies as Topic;
- Occupational Exposure [*prevention & control];
Medical Subject Headings Check Words
Adult; Humans;
